Home » Speciality Sections » Mechanistic & Discovery Toxicology speciality section

Mechanistic & Discovery Toxicology speciality section

Key information

Co-ordinators: Dr Nic Coltman & Dr Francisco Inesta-Vaquera

Get in touch:      mdt@thebts.org

The development of novel compounds for human exposure, particularly pharmaceuticals and personal care products, requires evaluation of the risk they pose to human health and wellbeing.

Mechanistic and discovery toxicology is the discipline focused on predictive toxicological and safety evaluation studies to provide an integrated evaluation of both target-related and chemical-related safety liabilities prior to advancement of compounds into nonclinical and clinical development.

The Mechanistic and Discovery Toxicology Speciality Section represents members involved with or interested in nonclinical and safety assessment methodologies, with utility in a discovery research environment.

This Speciality Section also leads on the provision of guidance and education around appropriate application of these approaches to refine or compliment current toxicological practices and frameworks used in research and development.